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Abstract
Background: Decision aids based on the philosophy of shared decision making are designed to help patients
make informed choices among diagnostic or treatment options by delivering evidence-based information on
options and outcomes. A patient decision aid can be regarded as a complex intervention because it consists of
several presumably relevant components. Decision aids have rarely been field tested to assess patients’ and
physicians’ attitudes towards them. It is also unclear what effect decision aids have on the adherence to chosen
options.
Methods: The electronic library of decision aids (arriba-lib) to be used within the clinical encounter has a modular
structure and contains evidence-based decision aids for the following topics: cardiovascular prevention, atrial
fibrillation, coronary heart disease, oral antidiabetics, conventional and intensified insulin therapy, and unipolar
depression. We conducted an evaluation study in which 29 primary care physicians included 192 patients. After the
consultation, patients filled in questionnaires and were interviewed via telephone two months later. We used
generalised estimation equations to measure associations within patient variables and traditional crosstab analyses.
Results: Patients were highly satisfied with arriba-lib and the process of shared decision making. Two-thirds of
patients reached in the telephone interview wanted to be counselled again with arriba-lib. There was a high
congruence between preferred and perceived decision making. Of those patients reached in the telephone
interview, 80.7% said that they implemented the decision, independent of gender and education. Elderly patients
were more likely to say that they implemented the decision.
Conclusions: Shared decision making with our multi-modular electronic library of decision aids (arriba-lib) was
accepted by a high number of patients. It has positive associations to general aspects of decision making in
patients. It can be used for patient groups with a wide range of individual characteristics.
Background
In shared decision making (SDM), patients are empow-
ered in a way that they actively ask questions and parti-
cipate in decisions about their health care on the basis
of their preferences and values [1,2]. In clinical practice,
patients are not regularly asked about their preferences
[3]. Scheibler et al. [4] present results where about one-
half of patients want to be involved in decision making,
but a far smaller percentage of them are actually
involved. The willingness of physicians to involve their
patients in decision making is considerably lower than
the preference of their patients. Physicians need to
assess their patients’ preferences before starting to dis-
cuss the reason for consultation [5].
Decision aids based on SDM are designed to help
patients make informed choices among diagnostic or
treatment options by delivering evidence-based informa-
tion on options and outcomes. They are supposed to
supplement the counselling process and can be delivered
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tion [6]. Decision aids are reported to increase knowl-
edge, reduce decisional conflict, cause greater
satisfaction with decision making, support more realistic
expectations, achieve a greater likelihood of being able to
make a decision, result in an increased association
between patient values and decisions, support patient
participation, and enhance communication between phy-
sicians, patients, and their relatives [7]. Decision aids
should not substitute personal counselling because
uncertain patients would then be abandoned [8]. Several
authors argue for the need to develop evidence-based
decision aids for a wide range of clinical applications that
should display this evidence on a basic level to be under-
standable for the patient. They should be interactive so
that individual risk data can be entered, and the effects of
certain treatments can be seen immediately. Pros and
cons can be discussed by using weighted scales [1].
A patient decision aid can be regarded as a complex
intervention because it consists of several presumably
relevant components. Therefore, there is a need to
model components of a complex intervention and to
perform exploratory trials to pre-test preliminary ver-
sions of an intervention. Outcomes of potential rele-
vance like patient characteristics might then represent
endpoints in later controlled trials [9]. Consequently,
decision aids require rigorous field testing to assess
patients’ and physicians’ attitudes towards them;
recently, several studies attempted to carry out such
field tests [10-12]. Therefore, it is strongly recom-
mended to evaluate decision support systems in a real
world setting with multi-perspective, multi-method stu-
dies ahead of dissemination for routine use. Such studies
should contain a variety of aspects, use multiple meth-
ods, apply flexible study designs with longitudinal mea-
sures, and do formative and summative evaluations.
Most studies in this area concentrate on physicians, not
on patients or other users [1,11,13-15].
We undertook a mixed method evaluation study using
quantitative and qualitative methods (patient interviews,
focus groups). The importance of mixed method
research in complex interventions like decision aids is
underlined by the study of Protheroe et al.[ 9 ] .I nt h e i r
pragmatic randomized controlled trial of a decision aid
for women who attended their primary care physician
because of menorrhagia, they found that women with
less formal education reported greater benefits in quali-
tative measures. In contrast, the quantitative analysis
revealed that women with more formal education bene-
fited most from the intervention. This inter-method dis-
crepancy emphasizes the need for a multi method
approach when examining such a complex intervention.
The aim of our study was to evaluate the acceptance
of SDM with reference to an interactive, transactional,
and evidence-based library of decision aids by patients
and physicians in the primary care context.
Methods
W ep e r f o r m e dam i x e dm e t h o de v a l u a t i o ns t u d y .
According to the taxonomy of mixed methods as
designed by Palinkas et al. [16], we sequentially col-
lected quantitative and qualitative data. Our intention
was to use the qualitative method to answer questions
raised by quantitative data (function: expansion). We
intended to build the qualitative data upon our quantita-
tive data set (process: connect). Here, we present quanti-
tative data of patients on the acceptance of SDM with
reference to our electronic library of decision aids
(arriba-lib) and its association with decision making.
The analyses of our comprehensive qualitative data and
the integration of quantitative and qualitative data will
be presented in different publications.
arriba-lib
Our electronic library of decision aids, arriba-lib, is an
extension of ARRIBA-Herz, a decision aid on cardiovas-
cular prevention that was investigated in a randomised
controlled trial [17], and which is now named ‘arriba™.’
The software, whereby ‘lib’ is an acronym for ‘library,’
has a modular structure and presently contains evi-
dence-based decision aids for the following topics: cardi-
ovascular prevention, atrial fibrillation, coronary heart
disease, oral antidiabetics, conventional and intensified
insulin therapy, and unipolar depression. Further mod-
ules are currently in development. Figure 1 displays the
opening screen of arriba-lib and shows the library-like
structure. It is a Java application that does not need an
installation process and is less than 15 megabyte.
The modules are structured to assist physicians in
counselling their patients according to the philosophy of
SDM [18,19]. In our programme, this process comprises
the following successive steps: definition of the problem,
discussion of the individual risk, discussion of treatment
options, deliberation, and plan for future actions where
‘no treatment’ is also a possible choice. These steps can
be regarded as a framework to help the clinician to effec-
tively structure the encounter. After typing in history
information, individual risk information is displayed by
smileys, bar charts, or curves (Figure 2). These smileys
are an easy-to-understand graphic representation of risk
information that takes the limited numeracy and statisti-
cal literacy of patients and physicians into account [20].
The presentation of global risk information was shown to
increase the accuracy of perceived risk [21]. Risk-redu-
cing effects can be demonstrated after choosing between
evidence-based treatment options. The process of delib-
eration can be supported by weighted scales mentioning
pros and cons related to each option (Figure 3).
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topics and communication strategies is also provided in
the programme and can be easily accessed in each mod-
ule. For the purpose of our study, log files of every con-
sultation were created that recorded every step taken in
the modules and how long it took to initiate the next
step. The results of these analyses will be presented
separately.
The participating physicians received a personal intro-
duction into the programme and the philosophy of
SDM by seminars, outreach visits, and a brochure
explaining details of the programme.
Recruitment and sampling
We invited a convenience sample of 91 primary care phy-
sicians in the German federal lands of North Rhine-
Westphalia and Hesse to participate in our study, of
which 34 agreed. Five of these 34 physicians failed to
recruit any patients, leaving 29 participating primary care
physicians who included 192 patients. Patients were
included when there was a decision to be made in the
topics covered by arriba-lib regardless of the stage of the
underlying disease. Physicians were told that they should
stop recruitment when they had included 10 consecutive
patients. Twenty-seven patients refused to participate,
and 18 patients fulfilled our exclusion criteria (restric-
tions because of language, cognitive abilities, psychiatric
disorder, and severity of somatic disease). On average,
recruitment of patients comprised a period of eight
weeks. The recruitment process is depicted in Figure 4.
The study complies with the Declaration of Helsinki.
The research protocol was approved by the local
research ethics committee at the University of Marburg.
All physicians and patients gave their written informed
consent. Our study corresponds to Phase II of the
model for complex interventions by the British Medical
Research Council [22].
Measurements
After each consultation, the physician and the patient
filled in questionnaires. The patient questionnaire con-
sisted of the SDM Questionnaire (SDM-Q), which
Figure 1 Opening screen of arriba-lib.
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according to theoretical frameworks [23], and the
Patient Participation Scale (PPS) [24] to measure patient
satisfaction and participation that consists of six items
which can be rated as follows: totally agree, agree,
neither...nor, disagree, or totally disagree. High scores
signify low participation in, as well as low satisfaction
with, the consultation. Additional details on these ques-
tionnaires are presented in Hirsch et al. [25]. We further
included questions on who made the decision, who
should make the specific treatment decision, and a glo-
bal rating of satisfaction with the encounter.
Qualitative semi-structured patient interviews were con-
ducted within one week after the consultation with those
patients who had agreed to be personally interviewed. In
those interviews, questions were asked about the accep-
tance of arriba-lib. After 20 interviews, saturation was
reached. Analyses of these qualitative data will be pub-
lished separately. Two months after the consultation,
patients were asked in structured telephone interviews
whether a decision had been made after the consultation
with arriba-lib, whether the decision had been implemen-
ted, and whether they would like to be counselled again
with arriba-lib.
Statistical methods
Because of the hierarchical structure of our data (patients
nested within physicians), we used generalised estimation
equations (GEE) to measure associations within patient
variables [26]. The Wald c
2-test was used as a test statis-
tic. To enhance the interpretability of the results, we also
analysed the data with traditional crosstab analyses (c
2-
test, Haldane-Dawson test, contingency coefficient).
Effect sizes Cramer V and Cohen’s d were used to mea-
sure the meaning of associations and differences [27].
Because of the exploratory nature of our study, we
decided not to adjust for multiple testing. This has to be
considered when interpreting the results [28].
Figure 2 Individual risk information with smileys. Within the module regarding oral antidiabetics (metformin), the risk to suffer from a
myocardial infarction or stroke in the next ten years compared to one hundred patients with the same characteristics is shown examplarily with
smileys.
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mum of 10% missing data on isolated variables that we
assumed as missing completely at random because there
were no patterns of associations with other variables [29].
Imputation of missing data was performed by inserting
the means of the respective variables on physician level;
in simulation studies, this was found to be most appro-
priate when the data had a hierarchical structure [30].
Results
The average age of the 29 participating primary care phy-
sicians was 52.2 years (sd 5.1 years; range: 43 to 64
years). Eighteen were male (62%). The average time prac-
ticing was 14 years (sd 7.5 years; range: 0 to 27 years).
The module for cardiovascular prevention was
selected in 128 patients (67%), the diabetes modules in
43 patients (22%), coronary heart disease in 8 patients
(4%), atrial fibrillation in 8 patients (4%), and depression
in 3 patients (2%).
The 45 patients who had been excluded from the
study did not differ significantly from participants
regarding gender (c
2 = 1.69, p=0.19) and age (t = 1.69,
p=0.09; d = 0.28). The medium age of the 192 partici-
pating patients was 62.4 years (sd 11.8 years; range: 23
to 83 years). There was an equal distribution regarding
gender, with 97 males (50.5%) and 95 females (49.5%). A
majority of 70.3% had a formal education of eight years
or less, 14.6% had a formal education of up to 10 years,
and 15.1% of more than 10 years. In our sample, 122
patients (63.5%) preferred SDM with their physicians,
and exactly the same proportion mentioned that SDM
actually had taken place.
In 46 patients (24.0%) the reason for consultation was
a check-up, 34 patients (17.7%) attended their physicians
for a monitoring visit, and 20 patients (10.4%) were seen
in the context of a disease management programme.
The remaining patients came with acute complaints or
to discuss results of laboratory examinations.
Figure 3 Weighted scales in arriba-lib for the deliberation phase.
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(69.3% of the original sample) took part in a short tele-
phone follow-up interview.
Acceptance of and satisfaction with shared decision
making and arriba-lib in patients
Table 1 depicts the patient’s data on the items of the
SDM-Q nested under different steps of the SDM pro-
cess. There were high ceiling effects, and a floor effect
in step five, where only a small fraction of patients had
mentioned other possibilities that their doctor had not
referred to. The majority of patients perceived that dif-
ferent aspects of the SDM process had actually taken
place.
Table 2 lists means and standard deviations of the
items of the Patient Participation Scale (PPS). The
means of all the items of the PPS were between the rat-
ing categories ‘totally agree’ and ‘agree.’ Therefore,
patients were highly satisfied with the encounter. In a
global rating, a very high proportion of patients (97.4%)
were ‘very satisfied’ or ‘satisfied’ with the consultation.
Two months after the consultation, patients were
asked in a telephone interview whether they would like
to be counselled again with arriba-lib. Of those asked,
65.2% wanted to be counselled again with arriba-lib,
18.9% had no defined preference, and 15.9% did not
remember the decision aid. There was no significant
association between gender and the further preference
Figure 4 Flow chart displaying the recruitment process in the
arriba-lib study.
Table 1 Steps of the shared decision making process as
reported by patients in the Shared Decision Making
Questionnaire (SDM-Q)
SDM-Q ’agree’(%)
Step 1: Disclosure that a decision needs to be made
My doctor told me that a treatment decision is necessary. 83.3
Step 2: Formulation of equality of partners
My doctor asked me if I want to participate in decision
making.
91.7
Step 3: Equipoise statement
Due to my medical condition, a treatment decision based
on the physicians’ recommendation is already clear.
78.6
Step 4: Informing on the options’ benefits and risks
My doctor has informed me about a variety of alternatives. 85.9
The possibility to choose no treatment was also discussed. 72.9
Step 5: Investigation of patient’s understanding and
expectations
I have mentioned other possibilities that my doctor has not
referred to.
19.8
My doctor has asked me what I think about different
treatment options.
77.6
Step 6: Identification of preferences (both)
I have communicated to my doctor which decision I prefer. 74.5
My doctor has told me which decision he prefers. 90.6
Step 7: Negotiation
In the selection of a treatment method, my thoughts were
taken into account just as much as the considerations of
my doctor.
97.4
My doctor and I thoroughly considered the different
treatment options.
93.2
Step 8: Shared decision making
My doctor enabled me to actively participate in decision
making about treatment.
88.5
My doctor and I selected a treatment together. 88.5
Step 9: Arrangement of follow-up
My doctor and I reached an agreement as to how we will
proceed.
92.2
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2 = 1.35, df = 1, p
= 0.25). Furthermore, there were no significant associa-
tions between age and preference for arriba-lib (GEE:
Wald-c
2 = 0.20, df = 1, p=0.65) and between education
and further preference for arriba-lib (GEE: Wald-c
2 =
6.11, df = 4, p=0.19).
Association of arriba-lib with decision making and
exploration of additional factors
In 70% of the responding patients, we found a perfect
match between preferred and perceived decision mak-
ing. Fifty-seven percent of the patients had preferred
and actually perceived SDM. This resulted in a contin-
gency coefficient of 0.65 (p <0 . 0 0 1 )a n dah i g he f f e c t
size (Cramer V = 0.39).
Of those patients reached in the telephone interview,
69.9% said that a decision had been made, and 80.7% of
them had implemented the decision. We found no sig-
nificant associations between gender (GEE: Wald-c
2 =
1.62, df = 1, p=0.20) or education (GEE: Wald-c
2 =
1.55, df = 4, p=0.82) and the patient’s indication that a
decision had been made. Elderly patients were more
likely to say that no decision could be made (GEE:
Wald-c
2 = 7.76, df = 1, p=0.005).
The implementation of patients’ decisions was inde-
pendent from gender (GEE: Wald-c
2 =0 . 3 7 ,d f=1 ,p=
0.54) and education (Haldane-Dawson-Test: z = 0.24, p
= 0.82). Elderly patients were more likely to say that
they implemented the decision (GEE: Wald-c
2 = 4.58, df
=1 ,p=0.03).
Discussion
We conducted a study to evaluate the acceptance of
SDM with reference to an interactive, transactional, and
evidence-based library of decision aids and its associa-
tions with decision making in patients in primary care
practice. The majority of patients perceived that differ-
ent aspects of the SDM process had actually taken
place. Patients were highly satisfied with the encounter.
In a brief telephone interview two months after the con-
sultation, two-thirds of the patients stated that they
would like to be counselled again with arriba-lib.
There was a high match between preferred and per-
ceived decision making in patients. More than two-thirds
of patients said that a decision could be made after the
consultation. This was not associated with gender or edu-
cation, but elderly patients were more likely to say that
no decision could be made. More than three-quarters of
those reached in the telephone interview implemented
the decision within an interval of two months after the
consultation. Elderly patients were more likely to say that
they had implemented the decision.
Our study has several limitations. It is possible that
physicians did not necessarily perform consecutive
patient recruitment, and instead treated some patients
as usual. This may have led to a positive selection of
patients who were already favourably inclined to SDM.
This positive selection bias concerning SDM may also
be true of the participating physicians because just 32%
of the invited physicians took part in our study. Results
of statistical analyses within a small evaluation study
should always be treated with caution and should be
regarded as preliminary [28]. We had no control group
in our study, so we cannot compare our results to the
situation of usual care.
There is a lack of an accepted primary outcome
regarding the use of decision aids. Possible categories to
classify measures of effectiveness are knowledge, deci-
sion process (e.g., satisfaction and participation prefer-
ence), decision outcomes (e.g., has a treatment decision
been made, adherence), health status, and economic
measures. In our sample, patients were highly satisfied
with arriba-lib and the process of SDM. Whether this
can be solely attributed to the programme is debatable.
In a different study, we found that patients were highly
satisfied with their physicians regardless of SDM being
applied or not [25]. This challenges patient satisfaction
to be an adequate measure in evaluating decision aids. It
further has to be mentioned that the questionnaires
used may have primarily measured satisfaction with the
SDM process or just patient satisfaction with their phy-
sician in general. Our telephone interviews have the
same limitations than other telephone surveys, e.g.,
social desirability. Validity checks were not possible
because we were not allowed to view patient records. It
was not recorded what kind of decisions had been
made. We were primarily interested in the acceptance of
an SDM approach in connection with our electronic
library. The implementation of a decision also depends
on what kind of decision was made.
Congruence between preferred and perceived decision
making predicted adherence to medical decisions, while
age and gender did not have any explanatory power
Table 2 Means and standard deviations of patient ratings
on the Patient Participation Scale
Mean (sd)
1. My doctor helped me to understand all of the
information.
1.18 (0.39)
2. My doctor understood what is important for me. 1.18 (0.40)
3. My doctor answered all of my questions. 1.17 (0.47)
4. I was sufficiently involved in decisions about my
treatment.
1.22 (0.48)
5. I have decided the further treatment together with my
doctor and I am satisfied with the result.
1.33 (0.68)
6. I am satisfied with the manner by which my treatment
has been discussed and decided.
1.20 (0.47)
The scale ranges from 1 (totally agree) to 5 (totally disagree).
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Jahng et al. because we also found a high congruence
between preferred and perceived decision making and a
high adherence to decisions.
Our findings suggest that our electronic library of
decision aids has a positive association with decision
making in patients and that future preference for it is
high, regardless of patient characteristics like gender,
education, or age. Sepucha et al. [32] report that people
with lower education, lower income, and high trust in
their doctor overestimate their state of being informed
about medical issues. Therefore, it is important that
physicians check the level of understanding in patients
during consultation with a decision aid.
In their updated systematic review, Légaré et al. found
time constraints, patient characteristics, and the clinical
situation to be the most often reported barriers for the
implementation of SDM [33,34]. On the basis of our
results, we agree with the authors that physicians should
not assume that patients with certain sociodemographic
characteristics are not fit for SDM. Instead, the encoun-
ter should be adapted to the individual patient.
Consequently, there is a need for constant evaluation
of measures used in the area of SDM. In the near future,
we will conduct a randomised controlled trial that will
attempt to find active ingredients in the risk-presenting
part of the programme. Different methods of risk pre-
sentation will be applied. Physicians and patients will be
asked which presentation they find most suitable. In
another study, we will check the validity of our cardio-
vascular prevention module by longitudinal epidemiolo-
gical data.
Conclusions
SDM with reference to our comprehensive electronic
library of decision aids (arriba-lib) was accepted by a
high number of patients. It has positive associations
with general aspects of decision making in patients and
can be used for patient groups with a wide range of
individual characteristics.
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